Form 4: Cardio Diagnostics Director James Intrater Settles Restricted Stock Units

Director James Intrater settled restricted stock units (RSUs) for Cardio Diagnostics Holdings, Inc. on March 31, 2024, resulting in the acquisition of 8,803 shares of common stock.

Summary

• On March 31, 2024, James Intrater, a director of Cardio Diagnostics Holdings, Inc., settled restricted stock units (RSUs).
• This transaction involved the vesting of $12,500 in value of RSUs, which were settled at a price of $1.42 per share.
• As a result, Intrater acquired 8,803 shares of common stock.
• Following the transaction, Intrater directly owns 71,596 shares of Cardio Diagnostics Holdings, Inc.
• The RSUs were granted pursuant to the company's 2022 Equity Incentive Plan and are subject to continued service with the issuer.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reflects a standard transaction related to executive compensation.

Positives

• The vesting of RSUs indicates a continued alignment of the director's interests with the company's performance.
• The director now directly owns 71,596 shares of the company's common stock.

Future Outlook

Remaining RSUs will continue to vest in $12,500 increments on June 30, 2024, September 30, 2024, and December 31, 2024, subject to continued service with the Issuer.

Industry Context

This filing is a routine disclosure related to executive compensation and equity ownership, common in publicly traded companies.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it slightly increases the number of outstanding shares.

Key Dates